News

Donna Wilcock, Ph.D., was awarded a $1.7 million National Institutes of Health grant for her lab’s exploration of adverse effects of two new Alzheimer’s disease drugs shown to slow the progression of cognitive decline.

The focus of the work done by Elizabeth Rhodus, Ph.D., is to enhance sensory input in order to improve behavioral symptoms in people with Alzheimer's disease and related dementias.

Linda J. Van Eldik, Ph.D., director of the University of Kentucky Sanders-Brown Center on Aging, is part of a $1.5 million grant to help further research into a possible treatment for Alzheimer’s disease.

Peter T. Nelson, M.D., Ph.D., professor of pathology and laboratory medicine at the University of Kentucky College of Medicine and director of neuropathology at the Sanders-Brown Center on Aging, has been named one of 14 University Research Professors.

A recent publication from UK researchers explains the importance of identifying and understanding how differences between tissues and cells alter gene expression without changing underlying genetic code.

A new UK College of Medicine study has identified potential targets to develop a therapy that could prevent Alzheimer’s disease. 

Research published from the Sanders-Brown Center on Aging is providing the most definitive assessment yet of the prevalence of a form of dementia classified in 2019 and now known as LATE.

The world’s first clinical trial for a form of dementia identified in 2019 is officially underway by researchers at the University of Kentucky's Sanders-Brown Center on Aging.

UK Women’s Basketball Coach Kyra Elzy is passionate about Alzheimer’s disease research because of her close relationships with her grandmother, Mary Elzy, and her college basketball coach.

A new program funded by a $1.5 million grant from the National Science Foundation will provide four years of scholarship support for up to 15 qualifying incoming students per year majoring in biology or neuroscience.